Results 171 to 180 of about 107,469 (263)
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin +22 more
wiley +1 more source
Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors. [PDF]
Umanath K, Dwyer JP, Mentz RJ.
europepmc +1 more source
Respiratory epithelial cells as central mediators of immune crosstalk in SARS-CoV-2 infection. [PDF]
Liu X +6 more
europepmc +1 more source
Impact of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Delirium Incidence in ICU Patients: A Retrospective Study. [PDF]
Li Z, Liu S, Wan Q, Niu Y, Yu Y.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı +4 more
wiley +1 more source
5/6 Nephrectomy as an Experimental Model for Chronic Kidney Disease: New Vasoactive and Antioxidant Therapeutic Targets. [PDF]
Aires RS +6 more
europepmc +1 more source
ABSTRACT Treatment of sarcoma includes high‐dose anthracyclines, which can cause cardiotoxicity. This study assesses the correlation of cardiac biomarkers and echocardiographic parameters on asymptomatic cardiotoxicity in sarcoma patients treated with anthracyclines.
Elissa A. S. Polomski +6 more
wiley +1 more source
Do stretch sensors expressed by aortic baroreceptors interact with circulating estradiol to mediate baroreflex sensitivity in hypertension? [PDF]
Salman S, Navarro G, Elsaafien K.
europepmc +1 more source
ABSTRACT The scope, organization, and biological significance of innate immune functions across structural cell types remain poorly defined. To address these fundamental knowledge gaps, we analyzed experimental data of transcriptomes generated by our group and others.
Juanjuan Liu +22 more
wiley +1 more source

